Drug Development

Apr 20, 2018
By Pharmaceutical Technology Editors
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
Apr 20, 2018
By Pharmaceutical Technology Editors
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
Apr 20, 2018
By Pharmaceutical Technology Editors
The new platform is expected to speed up cell line development.
Apr 19, 2018
By Pharmaceutical Technology Editors
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
Apr 19, 2018
By Pharmaceutical Technology Editors
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
Apr 16, 2018
By Pharmaceutical Technology Editors
Innomech has developed an innovative new test station for Fluidic Analytics to streamline R&D programs. The new test station serves as a labor-saving R&D tool to help process multiple test samples and to ensure product quality.
Apr 13, 2018
By Pharmaceutical Technology Editors
Pharmaceutical Technology will host a panel discussion focused on early drug development on April 24, 2018 at CPhI North America.
Apr 09, 2018
By Pharmaceutical Technology Editors
National Institutes of Health researchers use genomics to show that squamous cell carcinomas differ from other cancers, which could advance treatments for head and neck and other cancers.
Apr 09, 2018
By Pharmaceutical Technology Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Apr 09, 2018
By Pharmaceutical Technology Editors
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
native1_300x100
lorem ipsum